Danaher (NYSE:DHR) Issues Quarterly Earnings Results

Danaher (NYSE:DHR) released its quarterly earnings data on Thursday. The conglomerate reported $2.52 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.67 by $0.85, MarketWatch Earnings reports. The firm had revenue of $6.87 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 18.05% and a return on equity of 12.94%. The company’s revenue for the quarter was up 58.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.05 EPS.

Danaher stock traded up $8.44 during mid-day trading on Thursday, reaching $252.84. The company had a trading volume of 142,035 shares, compared to its average volume of 2,632,695. The company has a quick ratio of 1.68, a current ratio of 2.08 and a debt-to-equity ratio of 0.63. Danaher has a 52 week low of $155.30 and a 52 week high of $248.86. The company has a 50 day moving average of $225.15 and a 200-day moving average of $228.75. The firm has a market cap of $180.29 billion, a price-to-earnings ratio of 51.20, a PEG ratio of 1.92 and a beta of 0.72.

The business also recently declared a quarterly dividend, which will be paid on Friday, April 30th. Shareholders of record on Friday, March 26th will be issued a $0.21 dividend. The ex-dividend date of this dividend is Thursday, March 25th. This is an increase from Danaher’s previous quarterly dividend of $0.18. This represents a $0.84 dividend on an annualized basis and a yield of 0.33%. Danaher’s dividend payout ratio is 19.00%.

Several research analysts have weighed in on DHR shares. Credit Suisse Group upped their price objective on shares of Danaher from $260.00 to $264.00 and gave the company an “outperform” rating in a research note on Thursday, January 14th. Barclays began coverage on shares of Danaher in a research report on Monday, March 8th. They issued an “overweight” rating and a $260.00 target price for the company. Finally, Zacks Investment Research downgraded shares of Danaher from a “hold” rating to a “sell” rating and set a $241.00 target price for the company. in a research report on Friday, April 9th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and twelve have issued a buy rating to the company. Danaher currently has an average rating of “Buy” and an average target price of $237.33.

In other Danaher news, SVP Angela S. Lalor sold 6,437 shares of the stock in a transaction on Friday, February 12th. The shares were sold at an average price of $244.70, for a total value of $1,575,133.90. Following the completion of the sale, the senior vice president now directly owns 25,148 shares of the company’s stock, valued at approximately $6,153,715.60. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 11.70% of the stock is owned by corporate insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Further Reading: Dual Listing What You Need to Know

Earnings History for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.